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Bottlenecks to HIV care and treatment 
in sub-Saharan Africa: a multi-country 
qualitative study
Alison Wringe,1 Jenny Renju,1 Janet Seeley,2,7,3 Mosa Moshabela,3,4 
Morten Skovdal5,6
The expansion in the provision of life-
saving antiretroviral therapy (ART) in 
sub-Saharan Africa over the past 15 years 
has been an unprecedented achievement 
for public health. By the end of 2015, an 
estimated 10.3 million persons living with 
HIV (PLHIV) were receiving ART in 
southern and eastern Africa, the most 
affected region in the world. Just over half 
of all PLHIV in the region are now 
receiving ART, more than double the 
number just 3 years earlier.1
ART scale-up has dramatically reduced 
HIV-related mortality and morbidity, 
bringing countless social and economic 
benefits to communities that had been 
hard hit by the epidemic. The network 
for Analysing Longitudinal Population 
data on HIV/AIDS (ALPHA), a collabo-
ration among 10 health and demographic 
surveillance system (HDSS) sites in east 
and southern Africa, has been investi-
gating declines in adult mortality and their 
causes in seven countries (www. lshtm. ac. 
uk/ alpha).2 Recent analyses from seven 
sites indicate a substantial impact of HIV 
treatment programmes on adult mortality 
following the expansion of ART, with 
declines ranging from 58% to 84%.3
Despite this progress, there remains a 
substantial deficit in overall life expectancy 
among adults living with HIV, with their 
survival between 5 and 10 years less than 
among uninfected adults.4 These ‘excess’ 
deaths among PLHIV are occurring due 
to late diagnosis, poor linkage to care and 
treatment, and ART interruptions.5 By the 
end of 2015, an estimated 44% of PLHIV 
in southern and eastern Africa remained 
undiagnosed,6 and rates of linkage to 
care after diagnosis range widely from 
17% to 78%, while ART initiation among 
those eligible for treatment ranges from 
14% to 95%.7 A number of studies have 
documented reasons for delays in testing, 
and initiating and adhering to treatment 
including beliefs that treatment is for 
people who are sick, fear of side effects 
and concerns about stigma.8–11
In 2014, the Joint United Nations 
Programme on HIV and AIDS and part-
ners set the ‘90-90-90 targets’ to drive 
the efforts for AIDS elimination by 2030, 
prompting the widespread adoption of 
‘test and treat’ strategies. Understanding 
and addressing these existing bottlenecks 
in HIV care and treatment will be crit-
ical to attaining the 90-90-90 targets and 
achieving a future free of AIDS. Quali-
tative research can help to elucidate the 
social norms, practices and interactions 
that drive patients’ varied engagement 
with HIV care and treatment services 
in different contexts. By exploring the 
perspectives of HIV service users, their 
family member and health providers, it 
is possible to elicit how the interactions 
between patients and health services take 
form and are shaped by broader commu-
nity responses to the epidemic.
In this context, we undertook a multi-
country qualitative study to explore the 
bottlenecks to HIV care and treatment 
in seven HDSS sites  within the ALPHA 
Network: Kisumu (Kenya), Rakai, Kyam-
baliwa (Uganda), Kisesa (Tanzania), 
Karonga (Malawi), uMkhanyakude (South 
Africa) and Manicaland (Zimbabwe). The 
overall aim of the ‘Bottlenecks Study’ 
was to explore how contextual, social 
and health systems factors influence the 
engagement of PLHIV with HIV care 
and treatment in seven HDSS in sub-Sa-
haran Africa. By undertaking the research 
in health and demographic surveillance 
sites, we were able to sample PLHIV with 
different HIV care and treatment histories, 
including those who had been diagnosed 
but not yet initiated care, or those who 
had disengaged from the HIV care process. 
Both of these groups are notoriously diffi-
cult to include in qualitative studies, partly 
due to difficulties in recruiting them in 
the absence of household identifiers and 
preobtained consent to contact them 
for research purposes. As a result, their 
voices and stories are often missing from 
accounts of HIV service use, which can 
risk focusing policy recommendations on 
those who face relatively fewer challenges 
to HIV care engagement. Furthermore, the 
availability of verbal autopsy data sets in 
HDSS sites, used to assign cause of death 
for better HIV surveillance, enabled us to 
contact and interview the family members 
of some PLHIV who had died from 
AIDS-related causes, providing a rarely 
obtained family member’s perspective of 
the events and circumstances surrounding 
the death of their relative. Further details 
on the sampling frames, study settings 
and methods for the study in each site are 
available as online Supplementary file 1.
Undertaking a qualitative study across 
so many settings presents a multitude 
of challenges, as well as opportunities, 
not least in relation to the analysis and 
interpretation of the data. In our study, 
all of the sites had some characteristics 
in common, namely their rural nature, 
similar provision of HIV treatment 
services through small health centres 
and dispensaries since 2004–2005, and a 
generalised HIV epidemic. Despite these 
similarities, drawing out comparisons 
between study sites in qualitative studies 
can be complex, because some apparent 
differences may reflect how the data were 
produced, rather than variation in the 
implementation of national HIV policies 
or sociocultural contexts, with the former 
being more complex to attribute to the 
observed differences in the data. For 
these reasons, for each paper, we chose to 
include data from sites where the findings 
were broadly similar.
In this special issue of Sexually Trans-
mitted Infections, we present the findings 
from the Bottlenecks Study. We chose to 
explore patients’ experiences at different 
stages of HIV care and treatment, that 
is, HIV testing, access to ART and reten-
tion, with a view to understanding how 
PLHIV, in the context of their social 
worlds, interact with these HIV services. 
Combined, the papers provide an analyt-
ical spotlight to the multiple tensions that 
exist between HIV programmes and the 
complex social realities that often char-
acterise the lives of PLHIV in each study 
setting.
In a guest editorial to this special 
issue, Kielmann and Cataldo argue that 
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bottlenecks to HIV care and treatment 
can be situated historically in the context 
of previous ART roll-out approaches. 
They explore how spatial, temporal and 
relational parameters of the current drive 
towards universal test-and-treat models 
have evolved over the past 15 years.12
In the first research article in this special 
issue, Wringe and colleagues consider how 
experiences of PLHIV during their HIV 
testing encounters in the different HDSS 
may influence subsequent engagement in 
HIV care.13 They show that some of the 
principles that should underlie all HIV 
testing and counselling practices, such as 
consent, confidentiality and good quality 
counselling, may be modified or omitted 
by health workers to achieve perceived 
health benefits or policy targets. They 
argue that while such actions arguably 
save lives and increase HIV diagnosis 
rates, they may also jeopardise efforts to 
connect many diagnosed PLHIV to the 
long-term HIV care necessary for elimina-
tion of AIDS by 2030.
Bukenya and colleagues14 focus their 
research on those PLHIV who, despite 
knowing their HIV status, have not yet 
initiated HIV treatment. In trying to 
understand why this is the case, they 
unravel a range of persistent barriers 
pertaining to the affordability, availability 
and acceptability of HIV services. The 
barriers suggest that current models of 
HIV care and delivery still fail to consider 
the sociocultural context and economic 
position of PLHIV. The authors call for 
greater patient-centredness in the delivery 
of HIV care and treatment.
In their paper, Renju and colleagues 
pick up on an observation also made by 
Bukenya et al, namely that embodied 
experiences of HIV influence their accep-
tance of ART.15 The authors also note 
that across all the study sites, health 
providers, in an effort to achieve viral 
suppression, often failed to recognise the 
immediate needs that PLHIV face when 
enduring debilitating side effects. This 
could contribute to disengagement with 
HIV services, particularly among PLHIV 
who had not experienced the transforma-
tional effects of ART. They hypothesise 
that PLHIV who have not experienced 
AIDS-defining illnesses are less likely to 
find the motivation for tolerating incapac-
itating side effects that are common with 
ART.
The study by McLean and colleagues 
on Option B+ for the prevention of 
mother-to-child transmission services in 
Malawi, Tanzania and Uganda highlights 
the importance of identifying and capital-
ising on factors that motivate engagement 
with HIV care and treatment attenuating 
the impact of potential barriers.16 They 
found that a woman’s role as a mother was 
a powerful motivator to accept HIV care 
and treatment, over-riding other barriers 
to starting ART. Healthcare workers used 
the narrative of ‘protecting the unborn 
child’ tactically to amplify the benefits of 
this motivator.
Bonnington and colleagues examine 
the role of stigma in shaping engagement 
with HIV services in all of the study sites. 
By looking at the temporality of stigma 
(stigma in the everyday, over biograph-
ical time or historically), the authors 
disentangle different manifestations of 
stigma.17 They highlight how stigmatising 
attitudes, in their multiple and temporal 
forms, often disrupt testing and can also 
contribute to the termination of postdiag-
nosis care. They call for stigma mitigation 
strategies that consider the temporality of 
stigma, tailored to the different stages of 
HIV care.
The interactions between patients and 
providers throughout the spectrum of 
HIV care and treatment services also influ-
ence patient engagement in care. Ondenge 
and colleagues elicit some of the broader 
contextual factors and dynamics that 
shape patient–provider interactions in five 
of the study sites.18 Their analysis demon-
strates that patient–provider interactions 
are complex, multidimensional, deeply 
embedded in wider social dynamics and 
shaped by multiple ecological domains. 
They argue that greater efforts are needed 
to enhance patient–provider dialogue and 
empower patients to make decisions about 
their own health to improve their engage-
ment in HIV care.
National HIV programmes are not 
the only providers of HIV care. Mosha-
bela and colleagues look at the multitude 
of actors engaged with HIV care and 
examine how biomedical HIV services 
intersect with traditional, complemen-
tary and alternative medicine and care 
in all the sites.19 They find that although 
traditional/faith-based care was mostly 
treated as secondary and complemen-
tary to biomedical treatment, medical 
pluralism mediated pathways to HIV care 
continuum through treatment delays and 
interruptions and further fuelled fears of 
drug-to-drug interactions. The authors call 
for more collaborative culture-sensitive 
approaches to healthcare in sub-Saharan 
Africa.
Wamoyi and colleagues draw our atten-
tion to the interplay between couple 
dynamics and HIV care-seeking behaviour 
in South Africa, Tanzania and Malawi.20 
Their analysis reveals that couple 
dynamics influenced engagement with 
HIV testing, care and treatment for both 
partners through a myriad of pathways. 
Supportive partnerships could strengthen 
engagement with HIV services; however, 
for many couples, fear of blame, abandon-
ment or abuse resulted in unwillingness to 
disclose HIV status to each other. Many 
couples therefore did not engage with 
HIV services together, and instead allowed 
secrecy and mistrust to interfere with their 
HIV treatment and care.
By way of summarising, Skovdal and 
colleagues consider the potential of 
‘theories of practice’ for studying and 
understanding these varied engagements 
with HIV services across all of the partic-
ipating sites.21 Their theoretical bird’s-eye 
perspective suggests that engagement with 
HIV services is contingent on the avail-
ability, absence and connections between 
requisite ‘materialities’ (eg, health infra-
structure, medicines), ‘competencies’ (eg, 
knowing what and knowing how to live 
with HIV) and ‘meanings’ (eg, trust in 
HIV services, stigma, normalisation of 
HIV) and other life practices.
In conclusion, the papers in this volume 
illustrate how the ability of PLHIV to 
engage with HIV services is limited by a 
range of relational, symbolic, material and 
institutional factors in study settings across 
eastern and southern Africa. Greater 
acknowledgement of these issues, and 
imaginative, bold approaches to address 
them, must be at the forefront of policies 
and programmes to deliver HIV care and 
treatment, if the ambitious goal of AIDS 
elimination by 2030 is to be reached.
Handling editor Jackie A Cassell
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